1473 related articles for article (PubMed ID: 10589103)
1. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
2. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
[TBL] [Abstract][Full Text] [Related]
3. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
4. Modulation of gene expression by moxonidine in rats with chronic renal failure.
Vonend O; Apel T; Amann K; Sellin L; Stegbauer J; Ritz E; Rump LC
Nephrol Dial Transplant; 2004 Sep; 19(9):2217-22. PubMed ID: 15266031
[TBL] [Abstract][Full Text] [Related]
5. Pouch tissue and angiotensin peptide generation.
Katwa LC; Sun Y; Campbell SE; Tyagi SC; Dhalla AK; Kandala JC; Weber KT
J Mol Cell Cardiol; 1998 Jul; 30(7):1401-13. PubMed ID: 9710808
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
7. The renin-angiotensin system and compensatory renal hypertrophy in the rat.
Valentin JP; Sechi LA; Griffin CA; Humphreys MH; Schambelan M
Am J Hypertens; 1997 Apr; 10(4 Pt 1):397-402. PubMed ID: 9128205
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
9. Renoprotective properties of pirfenidone in subtotally nephrectomized rats.
Takakuta K; Fujimori A; Chikanishi T; Tanokura A; Iwatsuki Y; Yamamoto M; Nakajima H; Okada M; Itoh H
Eur J Pharmacol; 2010 Mar; 629(1-3):118-24. PubMed ID: 20006961
[TBL] [Abstract][Full Text] [Related]
10. Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys.
Miyazaki T; Ise M; Seo H; Niwa T
Kidney Int Suppl; 1997 Nov; 62():S15-22. PubMed ID: 9350672
[TBL] [Abstract][Full Text] [Related]
11. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
Jackson B; Cubela R; Debrevi L; Whitty M; Johnston CI
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S167-9. PubMed ID: 2455124
[TBL] [Abstract][Full Text] [Related]
12. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats.
Jones CL; Buch S; Post M; McCulloch L; Liu E; Eddy AA
Am J Pathol; 1992 Dec; 141(6):1381-96. PubMed ID: 1281619
[TBL] [Abstract][Full Text] [Related]
13. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
Noda M; Fukuda R; Matsuo T; Ohta M; Nagano H; Imura Y; Nishikawa K; Shibouta Y
Kidney Int Suppl; 1997 Dec; 63():S136-9. PubMed ID: 9407442
[TBL] [Abstract][Full Text] [Related]
14. Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors.
Kohzuki M; Kanazawa M; Liu PF; Kamimoto M; Yoshida K; Saito T; Yasujima M; Sato T; Abe K
J Hypertens; 1995 Dec; 13(12 Pt 2):1785-90. PubMed ID: 8903652
[TBL] [Abstract][Full Text] [Related]
15. Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure.
Noda M; Matsuo T; Fukuda R; Ohta M; Nagano H; Shibouta Y; Naka T; Nishikawa K; Imura Y
Kidney Int; 1999 Sep; 56(3):898-909. PubMed ID: 10469358
[TBL] [Abstract][Full Text] [Related]
16. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.
Mizobuchi M; Morrissey J; Finch JL; Martin DR; Liapis H; Akizawa T; Slatopolsky E
J Am Soc Nephrol; 2007 Jun; 18(6):1796-806. PubMed ID: 17513326
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis.
Ji Z; Huang C; Liang C; Chen B; Chen S; Sun W
Cell Mol Immunol; 2005 Apr; 2(2):150-4. PubMed ID: 16191423
[TBL] [Abstract][Full Text] [Related]
19. Appearance and regression of rat pouch tissue.
Zhang J; Sun Y; Zhang JQ; Ramires FJ; Weber KT
J Mol Cell Cardiol; 1999 May; 31(5):1005-13. PubMed ID: 10336840
[TBL] [Abstract][Full Text] [Related]
20. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
Song J; Meng L; Li S; Qu L; Li X
Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]